Phase I/II study of HSCT from HLA-matched donor using post-transplant cyclophosphamide
Phase 1
- Conditions
- AML, ALL, NHL. MDS
- Registration Number
- JPRN-UMIN000028779
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) positive for HBs Ag 2) positive for HIV Ag 3) depression 4) pregnancy 5) coexisting active cancer 6) active infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success rate at 6 months.
- Secondary Outcome Measures
Name Time Method